Diadem Biotherapeutics
Diadem Biotherapeutics (Diadem) engineers signalling proteins to display on the surface of cell-derived vesicles (exosomes) to treat cancer, chronic inflammation and autoimmune diseases. Diadem’s engineered exosomes mimic natural cell signaling in an agonist (activating) manner through clinically validated immune checkpoint receptors that play a role in autoimmune diseases or immune control of cancer.